NCT Number: NCT03426475
Previously,six measures were developed for a better collaboration of general practitioners and nurses in nursing homes in a qualitative multistep bottom-up process. These measures, summarised as the interprof ACT intervention, shall improve the flow of information and the communication between the involved parties and lead to more transparency and effectiveness regarding treatment decisions of nursing home residents.The major aim of this trial is to examine the clinical effectiveness of interprof ACT. The main hypothesis is that implementation of interprof ACT reduces the cumulative incidence of hospitalisations of nursing home residents within 12 months from 50% to 35% (15% absolute reduction).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Department of General Practice, University Medical Center Göttingen, Göttingen, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Residents:
Inclusion criteria
Nursing Homes:
Exclusion criteria
Residents:
Exclusion criteria
Nursing Homes:
Definition of common goals between general practitioner and nursing staff, appointment of a contact person, support in assigning medication, use of name badges worn by GPs and nurses during visits, mandatory availability of contact person, standardized procedures for GPs home visits
Time frame: within 12 months
Cumulative incidence of hospitalisations from nursing home residents within 12 months
Time frame: within 12 months
number of hospitalisations within 12 months
Time frame: within 12 months
Hospital days within 12 months
Time frame: within 12 months
mortality within 12 months
Time frame: baseline and after 6 and 12 months
potentially inadequate medications at baseline and for follow-ups at 6 and 12 months
Time frame: within 12 months
Adverse Events within 12 months
Time frame: baseline and after 12 months
Residents' quality of life at baseline and at 12 months. Scale range is 15 - 60, with higher scores indicating higher QoL.
Time frame: baseline and after 12 months
The EQ-5D-5L consist of two self-rating components: the EQ-5D descriptive system and a visual analogue scale (EQ VAS). The EQ-5D descriptive system measures HRQL on the five dimensions "mobility", "self-care", "usual activities", "pain / discomfort" and "anxiety / depression". On each dimension participants can rate either "no problems" (0), "slight problems" (1), "moderate problems" (2), "severe problems" (3) or "extreme problems" (4), resulting in a score ranging from 0 (best) to 4 (worst). The scores of the single dimensions can be combined to a sum score ranging from 0 (best) to 20 (worst). In addition, so called "utility weights" can be attached to any possible combination of answers on the EQ-5D descriptive system which results in a utility score ranging from 0 (death) to 1 (full HRQL), which is then used to calculate quality-adjusted life years (QALYs). The EQ VAS ranges from 0 (worst imaginable health state) to 100 (best imaginable health state).
Time frame: within 12 months
use of other medical services within 12 months
Time frame: after 12 months
economic evaluation: efficiency (incremental cost-effectiveness ratio) and cost savings from payer and societal perspective
Time frame: after 12 months
Higher score values indicating better collaboration.
Time frame: after 12 months
Higher score values indicating more favourable attitudes.
University Medical Center Goettingen
Other
Effects of Strategies to Improve General Practitioner-nurse Collaboration and Communication in Regard to Hospital Admissions of Nursing Home Residents.
Acronym: interprof ACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
